Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Y | - |
dc.contributor.author | Hwang, J | - |
dc.contributor.author | Kim, M | - |
dc.contributor.author | Lee, W | - |
dc.date.accessioned | 2024-01-21T09:32:57Z | - |
dc.date.available | 2024-01-21T09:32:57Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 2003-02 | - |
dc.identifier.issn | 0951-4198 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/138897 | - |
dc.description.abstract | Tripamide is a drug widely used in clinical practice for the treatment of hypertension and edema. This work evaluated a screening method for Tripamide and its urinary metabolites in human urine, using high-performance liquid chromatography diode-array detection (HPLC/DAD). Identification of these metabolites was investigated by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS) after dosing with 15 mg Tripamide. Acid hydrolysis showed that Tripamide is conjugated in the body. Two suspected metabolites were detected by HPLC/DAD. HPLC/ESI-MS/MS analysis suggested that these metabolites were probably hydroxylated together with loss of the -NH2 group and dehydrogenation. These results will be useful in confirmation methods for Tripamide in doping control. Copyright (C) 2003 John Wiley Sons, Ltd. | - |
dc.language | English | - |
dc.publisher | JOHN WILEY & SONS LTD | - |
dc.subject | PLASMA | - |
dc.subject | METABOLITES | - |
dc.subject | FUROSEMIDE | - |
dc.title | Determination of Tripamide in human urine by high-performance liquid chromatography and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry | - |
dc.type | Article | - |
dc.identifier.doi | 10.1002/rcm.913 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | RAPID COMMUNICATIONS IN MASS SPECTROMETRY, v.17, no.4, pp.301 - 306 | - |
dc.citation.title | RAPID COMMUNICATIONS IN MASS SPECTROMETRY | - |
dc.citation.volume | 17 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 301 | - |
dc.citation.endPage | 306 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000180952800006 | - |
dc.identifier.scopusid | 2-s2.0-0037278891 | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.relation.journalWebOfScienceCategory | Spectroscopy | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Spectroscopy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | PLASMA | - |
dc.subject.keywordPlus | METABOLITES | - |
dc.subject.keywordPlus | FUROSEMIDE | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.